Clinical usefulness of mtTFA expression as a predictive marker in colorectal cancer patients treated with FOLFOX

被引：0
|
作者：
Yoshida, Y. [1 ,2 ]
Hasegawa, J. [1 ,2 ]
Nezu, R. [1 ,2 ]
Kim, Y. [1 ,2 ]
Hirota, M. [1 ,2 ]
Yoshikawa, K. [1 ,2 ]
Kawano, K. [1 ,2 ]
Izumi, H. [1 ,2 ]
Kohno, K. [1 ,2 ]
机构：
[1] Osaka Rosai Hosp, Japan Labour Hlth & Welf Org, Sakai, Osaka, Japan
[2] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4059
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical usefulness of mitochondrial transcription factor A expression as a predictive marker in colorectal cancer patients treated with FOLFOX
    Yoshida, Yoichiro
    Hasegawa, Junichi
    Nezu, Riichiro
    Kim, Yong-Kook
    Hirota, Masaki
    Kawano, Kiyoshi
    Izumi, Hiroto
    Kohno, Kimitoshi
    CANCER SCIENCE, 2011, 102 (03) : 578 - 582
  • [2] Prediction of response to FOLFOX in metastatic colorectal cancer by mtTFA
    Yoshida, Y.
    Hasegawa, J.
    Nezu, R.
    Kim, Y.
    Hirota, M.
    Yoshikawa, K.
    Ohashi, H.
    Kawano, K.
    Izumi, H.
    Kohno, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab:: A fluorescent in situ hybridization study
    Personeni, Nicola
    Fieuws, Steffen
    Piessevaux, Hubert
    De Hertogh, Gert
    De Schutter, Jef
    Biesmans, Bart
    De Roock, Wendy
    Capoen, An
    Debiec-Rychter, Maria
    Van Laethem, Jean-Luc
    Peeters, Marc
    Humblet, Yves
    Van Cutsem, Eric
    Tejpar, Sabine
    CLINICAL CANCER RESEARCH, 2008, 14 (18) : 5869 - 5876
  • [4] CLINICAL USEFULNESS OF CEA AS TUMOR-MARKER IN PATIENTS WITH COLORECTAL-CANCER
    FILELLA, X
    MOLINA, R
    BEDINI, JL
    JO, J
    JOSEPH, J
    BALLESTA, AM
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1990, 34 (04): : 107 - 110
  • [5] Clinical usefulness of ATBF1-A expression in breast cancer as a prognostic and predictive marker
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 145 - 145
  • [6] Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV
    Bruno Vincenzi
    Anna Maria Frezza
    Gaia Schiavon
    Chiara Spoto
    Raffaele Addeo
    Vincenzo Catalano
    Francesco Graziano
    Daniele Santini
    Giuseppe Tonini
    Supportive Care in Cancer, 2013, 21 : 1313 - 1319
  • [7] Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV
    Vincenzi, Bruno
    Frezza, Anna Maria
    Schiavon, Gaia
    Spoto, Chiara
    Addeo, Raffaele
    Catalano, Vincenzo
    Graziano, Francesco
    Santini, Daniele
    Tonini, Giuseppe
    SUPPORTIVE CARE IN CANCER, 2013, 21 (05) : 1313 - 1319
  • [8] Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX
    Chang, Myung Hee
    Lee, In Kyu
    Si, Yoon
    Lee, Kyu Sang
    Woo, In-Sook
    Byun, Jae Ho
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) : 317 - 323
  • [9] Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX
    Myung Hee Chang
    In Kyu Lee
    Yoon Si
    Kyu Sang Lee
    In-Sook Woo
    Jae Ho Byun
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 317 - 323
  • [10] Identification of the predictive genes for the response of colorectal cancer patients to FOLFOX therapy
    Lin, Hengjun
    Qiu, Xueke
    Zhang, Bo
    Zhang, Jichao
    ONCOTARGETS AND THERAPY, 2018, 11 : 5943 - 5955
12345